

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Fosphenytoin Sodium
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
NPC-06 to Pain Associated With Acute Herpes Zoster
Details : NPC-06 is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Acute Pain-associated with Herpes Zoster.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 29, 2022
Lead Product(s) : Fosphenytoin Sodium
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Fosphenytoin Sodium
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ready-to-dilute and room temperature stable, SESQUIENT is the only FDA-approved fosphenytoin that allows point-of-care storage, as well as fast and efficient administration in emergency rooms and intensive care units.
Product Name : Sesquient
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 08, 2020
Lead Product(s) : Fosphenytoin Sodium
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Fosphenytoin Sodium
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
NPC-06 to Acute Pain in Herpes Zoster
Details : NPC-06 is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Acute Pain-associated with Herpes Zoster.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 25, 2019
Lead Product(s) : Fosphenytoin Sodium
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Fosphenytoin Sodium
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in Cancer
Details : NPC-06 is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Pain, Neuropathic-associated with Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 12, 2018
Lead Product(s) : Fosphenytoin Sodium
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Fosphenytoin Sodium
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Aatif Husain
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Fosphenytoin is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Seizures.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 25, 2011
Lead Product(s) : Fosphenytoin Sodium
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Aatif Husain
Deal Size : Inapplicable
Deal Type : Inapplicable
